Cargando…

Pattern of cancer/testis antigen expression in lung cancer patients

Cancer/testis (CT) antigens represent promising targets for immunotherapy. We investigated the composite expression of 13 CT antigens by RT-PCR in 79 lung cancer tissues and by immunohistochemistry in 22 lung cancer tissues. In the 79 lung cancer tissues, MAGE-3 (42%) was expressed most frequently a...

Descripción completa

Detalles Bibliográficos
Autores principales:	KIM, YEONG-DAE, PARK, HAE-RIM, SONG, MYUNG-HA, SHIN, DONG-HOON, LEE, CHANG-HUN, LEE, MIN-KI, LEE, SANG-YULL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573764/ https://www.ncbi.nlm.nih.gov/pubmed/22294213 http://dx.doi.org/10.3892/ijmm.2012.896

Ejemplares similares

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer
por: Kim, Ye-Rin, et al.
Publicado: (2021)

Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells
por: Song, Myung-Ha, et al.
Publicado: (2017)

A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation
por: KIM, KANG-MI, et al.
Publicado: (2012)

Cancer/testis antigens (CTAs) expression in resected lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation
por: Kang, Jun, et al.
Publicado: (2015)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

Identification of tumor antigens in malignant mesothelioma
por: Kim, Ye-Rin, et al.
Publicado: (2017)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
por: Naik, Adviti, et al.
Publicado: (2022)

Derepression of Cancer/Testis Antigens in cancer is associated with distinct patterns of DNA Hypomethylation
por: Kim, Robert, et al.
Publicado: (2013)

Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
por: Yang, Ping, et al.
Publicado: (2022)

Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice
por: Lam, Runyi Adeline, et al.
Publicado: (2021)

Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers
por: Shida, Akiko, et al.
Publicado: (2020)

Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer
por: Lee, Sang Hee, et al.
Publicado: (2015)

BRAF V600E Mutation of Non-Small Cell Lung Cancer in Korean Patients
por: Ahn, Hyo Yeong, et al.
Publicado: (2023)

Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen
por: Bai, Rui, et al.
Publicado: (2022)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023)

Expression of cancer-testis antigen in patients with non-small cell lung cancer and its clinical relevance
por: Chen, Xin-Feng, et al.
Publicado: (2013)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

Detection of Kita-Kyushu Lung Cancer Antigen-1, a Cancer/Testis Antigen, in the Stomach Close to a Cancerous Condition
por: Otsuka, Toshikazu, et al.
Publicado: (2022)

The Role of Cancer-Testis Antigens as Predictive and Prognostic Markers in Non-Small Cell Lung Cancer
por: John, Thomas, et al.
Publicado: (2013)

Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer
por: REN, BIQIONG, et al.
Publicado: (2016)

The association of (18)F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients
por: Kim, Seong-Jang, et al.
Publicado: (2010)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Inducible expression of cancer-testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2016)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

At Which Stage of Gastric Cancer Progression Do Levels of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Increase? Application in Advanced Gastric Cancer Treatment
por: Han, Eui Soo, et al.
Publicado: (2014)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
por: Miyamoto, Ai, et al.
Publicado: (2022)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis
por: Rosenzweig, M A, et al.
Publicado: (2012)

Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2015)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

Inducible expression of antigen processing and antigen presentation molecules and cancer testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2015)

Cancer/testis antigen CAGE mediates osimertinib resistance in non-small cell lung cancer cells and predicts poor prognosis in patients with pulmonary adenocarcinoma
por: Yeon, Minjeong, et al.
Publicado: (2023)

Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells
por: Vo, Manh-Cuong, et al.
Publicado: (2017)

Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
por: Khan, Ghazala, et al.
Publicado: (2015)

Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
por: Mooney, Steven M, et al.
Publicado: (2016)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects()
por: Wei, Xiao, et al.
Publicado: (2019)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
por: Jakobsen, Mie K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_trjs10gl4i53iedd0nhr2csotd